PL361056A1 - Zastosowanie porowatego nośnika - Google Patents

Zastosowanie porowatego nośnika

Info

Publication number
PL361056A1
PL361056A1 PL01361056A PL36105601A PL361056A1 PL 361056 A1 PL361056 A1 PL 361056A1 PL 01361056 A PL01361056 A PL 01361056A PL 36105601 A PL36105601 A PL 36105601A PL 361056 A1 PL361056 A1 PL 361056A1
Authority
PL
Poland
Prior art keywords
porous carrier
drug
loaded
controlled release
interconnected porosity
Prior art date
Application number
PL01361056A
Other languages
English (en)
Inventor
Rodney Martin Sambrook
Wayne Austin
Mark Rodney Sambrook
Michael Hannon
Original Assignee
Dytech Corporation Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dytech Corporation Ltd. filed Critical Dytech Corporation Ltd.
Publication of PL361056A1 publication Critical patent/PL361056A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Porous Artificial Stone Or Porous Ceramic Products (AREA)
  • Filtering Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
PL01361056A 2000-08-21 2001-08-21 Zastosowanie porowatego nośnika PL361056A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0020610.2A GB0020610D0 (en) 2000-08-21 2000-08-21 Uses of porous carriers

Publications (1)

Publication Number Publication Date
PL361056A1 true PL361056A1 (pl) 2004-09-20

Family

ID=9898036

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01361056A PL361056A1 (pl) 2000-08-21 2001-08-21 Zastosowanie porowatego nośnika

Country Status (17)

Country Link
US (1) US20040265350A1 (pl)
EP (1) EP1311241B1 (pl)
JP (1) JP2004506679A (pl)
KR (1) KR20030040418A (pl)
CN (1) CN1469736A (pl)
AT (1) ATE420626T1 (pl)
AU (2) AU2001279970B2 (pl)
BR (1) BR0113429A (pl)
CA (1) CA2420194A1 (pl)
DE (1) DE60137431D1 (pl)
ES (1) ES2321479T3 (pl)
GB (1) GB0020610D0 (pl)
HU (1) HUP0303111A3 (pl)
MX (1) MXPA03001546A (pl)
PL (1) PL361056A1 (pl)
RU (1) RU2283140C2 (pl)
WO (1) WO2002015881A2 (pl)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
GB0311221D0 (en) * 2003-05-15 2003-06-18 Orthogem Ltd Biomaterial
JP2005060307A (ja) * 2003-08-12 2005-03-10 Pirumu:Kk 骨造成剤
US8529625B2 (en) * 2003-08-22 2013-09-10 Smith & Nephew, Inc. Tissue repair and replacement
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
WO2005041936A2 (en) * 2003-10-21 2005-05-12 Psimedica Limited Methods of treatment of cancer using a composition comprising a cytotoxic drug and a porous carrier material
WO2005121288A1 (ja) * 2004-06-10 2005-12-22 Ntn Corporation 摺動材料およびすべり軸受
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
KR100858699B1 (ko) * 2005-01-25 2008-09-17 주식회사 한불후치피아 동·식물성 식품의 가용성 성분을 유효성분으로 함유하는 식품 및 그 제조방법
US8227365B2 (en) * 2005-06-08 2012-07-24 Ramachandran Nageswaran Biocidal ceramic compositions, methods and articles of manufacture
WO2007061889A2 (en) 2005-11-17 2007-05-31 Biomimetic Therapeutics, Inc. Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
US7939092B2 (en) 2006-02-01 2011-05-10 Warsaw Orthopedic, Inc. Cohesive osteogenic putty and materials therefor
US7824703B2 (en) 2006-02-01 2010-11-02 Warsaw Orthopedics, Inc. Medical implants with reservoir(s), and materials preparable from same
EP1991282B1 (en) 2006-02-09 2013-06-19 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
US8583208B2 (en) * 2006-02-23 2013-11-12 University Corporation, Kanazawa Institute Of Technology Superconducting magnetism measuring apparatus, biomagnetism measuring apparatus, and sensor cylinder cover and sheet for biomagnetism measuring apparatus
CA2644429C (en) 2006-03-14 2014-07-29 Lidds Ab Bioresorbable controlled-release composition
US20070258903A1 (en) * 2006-05-02 2007-11-08 Kleiner Lothar W Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers
CA2656278C (en) 2006-06-30 2016-02-09 Biomimetic Therapeutics, Inc. Compositions and methods for treating rotator cuff injuries
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US8106008B2 (en) 2006-11-03 2012-01-31 Biomimetic Therapeutics, Inc. Compositions and methods for arthrodetic procedures
DE102006060938A1 (de) * 2006-12-20 2008-06-26 Wolter, Dietmar F., Prof. Dr. Materialdepot zur Abgabe eines antibakteriellen Wirkstoffmaterials
WO2008095307A1 (en) * 2007-02-07 2008-08-14 Mcgill University Bioceramic implants having bioactive substance
CN101820895A (zh) * 2007-06-04 2010-09-01 生物模拟治疗公司 用于治疗脊柱的组合物和方法
EP2014256A1 (en) * 2007-07-12 2009-01-14 Straumann Holding AG Composite bone repair material
KR100977214B1 (ko) * 2007-10-09 2010-08-24 단국대학교 산학협력단 약물－함입 인산칼슘 복합박막
EP2617440B1 (en) * 2007-10-29 2017-01-11 Zimmer, Inc. Medical implants and methods for delivering biologically active agents
ES2422259T3 (es) 2008-02-07 2013-09-10 Biomimetic Therapeutics Inc Composiciones para la osteogénesis por distracción
WO2009108935A2 (en) * 2008-02-28 2009-09-03 Osteotherapeutics, L.L.C. Method and apparatus for impregnating porous biomaterials with bioactive agents
US20090248162A1 (en) * 2008-03-25 2009-10-01 Warsaw Orthopedic, Inc. Microparticle delivery syringe and needle for placing suspensions and removing vehicle fluid
US9616205B2 (en) 2008-08-13 2017-04-11 Smed-Ta/Td, Llc Drug delivery implants
EP2326281A4 (en) * 2008-08-13 2013-05-29 Smed Ta Td Llc ORTHOPEDIC IMPLANT WITH POROUS STRUCTURAL ELEMENT
WO2010019781A1 (en) 2008-08-13 2010-02-18 Smed-Ta/Td, Llc Drug delivery implants
US10842645B2 (en) 2008-08-13 2020-11-24 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
US9700431B2 (en) 2008-08-13 2017-07-11 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
ES2647919T3 (es) 2008-08-13 2017-12-27 Smed-Ta/Td, Llc Implantes de suministro de fármaco
JP5687622B2 (ja) 2008-08-29 2015-03-18 スメド−ティーエイ／ティーディー・エルエルシー 整形外科インプラント
RU2518528C2 (ru) * 2008-09-09 2014-06-10 Конинклейке Филипс Электроникс Н.В. Терапевтическая система для выделения энергии
KR20110067035A (ko) 2008-09-09 2011-06-20 바이오미메틱 세라퓨틱스, 인크. 건 및 인대 손상의 치료를 위한 혈소판-유래 성장 인자 조성물 및 방법
WO2010029474A1 (en) * 2008-09-09 2010-03-18 Koninklijke Philips Electronics N.V. Therapy system for depositing energy
CA2750605C (en) 2009-01-23 2019-01-22 Royal College Of Surgeons In Ireland Layered scaffold suitable for osteochondral repair
CN107080834A (zh) 2010-02-22 2017-08-22 生物模拟治疗有限责任公司 用于治疗腱病的血小板衍生生长因子组合物和方法
US20110270168A1 (en) * 2010-05-03 2011-11-03 Izhar Halahmi Releasing device for administering a bio-active agent
DK2569342T3 (da) 2010-05-11 2022-04-19 Howmedica Osteonics Corp Multivalente organofosformetalforbindelser og interpenetrerende polymerklæbemiddelnetværkssammensætninger og fremgangsmåder
US9119887B2 (en) 2010-09-16 2015-09-01 Mo-Sci Corporation Low-density magnesium-aluminum-silicate (MAS) microparticles for radiotherapy and/or radioimaging
ES2404733B2 (es) * 2011-10-05 2013-09-17 Universidad De Extremadura Andamiaje híbrido bioactivo, método de fabricación y uso para ingeniería de tejido óseo.
EP2790678A4 (en) * 2011-12-16 2015-09-30 Celanese Eva Performance Polymers Inc CONTROLLED RELEASE EXCIPIENTS COMPRISING ETHYLENE COPOLYMERS, ETHYLCELLULOSES AND / OR THERMOPLASTIC POLYURETHANES
JP6219841B2 (ja) * 2011-12-21 2017-10-25 アイソセラピューティクス グループ リミティド ライアビリティー カンパニーＩｓｏＴｈｅｒａｐｅｕｔｉｃｓ Ｇｒｏｕｐ ＬＬＣ 放射性構成物およびそれらの治療的使用方法
CN103043635B (zh) * 2012-12-25 2015-04-22 浙江大学 一种抗耐药性的顺铂矿化液及其制备方法和应用
WO2014195139A1 (en) * 2013-06-05 2014-12-11 Koninklijke Philips N.V. Adaptor
RU2590859C1 (ru) * 2015-06-30 2016-07-10 государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СибГМУ Минздрава России) Способ дистантной стимуляции регенерации гепатоцитов
CN106268299B (zh) * 2016-08-22 2019-03-29 湖北格林森绿色环保材料股份有限公司 一种微孔介质催化氧化制备空气净化材料的方法及空气净化材料
CN106377983B (zh) * 2016-10-31 2019-02-12 彭伟 一种纳米藻酸钛空气净化材料及其制备方法
CN108066766B (zh) * 2017-12-04 2021-08-31 北京派尔特医疗科技股份有限公司 一种丝材微孔陶瓷层载药方法及系统
RU2770074C1 (ru) * 2021-09-20 2022-04-14 Федеральное государственное бюджетное образовательное учреждение высшего образования «Тамбовский государственный технический университет» (ФГБОУ ВО «ТГТУ») Комбинированный полидисперсный инертный носитель для сушки измельченных растительных материалов

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218255A (en) * 1976-08-30 1980-08-19 University Of Dayton Porous ceramic carriers for controlled release of proteins, polypeptide hormones, and other substances within human and/or other mamillian species and method
JPS55122710A (en) * 1979-02-13 1980-09-20 Kyocera Corp Ceramic small granule for drug administration
JPS59131346A (ja) * 1983-01-17 1984-07-28 日本特殊陶業株式会社 薬液含浸多孔質セラミツクスの製造法
US4737411A (en) * 1986-11-25 1988-04-12 University Of Dayton Controlled pore size ceramics particularly for orthopaedic and dental applications
JPH01151461A (ja) * 1987-12-08 1989-06-14 Koransha Co Ltd 生体用補綴材料
JP2702953B2 (ja) * 1988-01-30 1998-01-26 オリンパス光学工業株式会社 薬液含浸セラミックス
JP2842647B2 (ja) * 1988-12-29 1999-01-06 旭光学工業株式会社 薬剤徐放性顆粒及びその製造方法
US5356630A (en) * 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US5626862A (en) * 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
GB9515242D0 (en) * 1995-07-25 1995-09-20 Ecc Int Ltd Porous mineral granules
JPH0987203A (ja) * 1995-09-27 1997-03-31 Kanegafuchi Chem Ind Co Ltd 薬剤含有粒子及びその製造方法
GB2354518B (en) * 1996-10-04 2001-06-13 Dytech Corp Ltd A porous ceramic body composed of bonded particles
CA2285430C (en) * 1997-04-01 2008-11-18 Cap Biotechnology, Inc. Calcium phosphate microcarriers and microspheres
US6296667B1 (en) * 1997-10-01 2001-10-02 Phillips-Origen Ceramic Technology, Llc Bone substitutes
JP3400740B2 (ja) * 1999-04-13 2003-04-28 東芝セラミックス株式会社 リン酸カルシウム系多孔質焼結体およびその製造方法
US6767550B1 (en) * 2000-06-30 2004-07-27 Berkeley Advanced Biomaterials, Inc. Hydroxyapatite based drug delivery implant for cancer treatment

Also Published As

Publication number Publication date
ES2321479T3 (es) 2009-06-08
WO2002015881A3 (en) 2002-06-27
JP2004506679A (ja) 2004-03-04
GB0020610D0 (en) 2000-10-11
BR0113429A (pt) 2004-04-06
HUP0303111A3 (en) 2007-03-28
MXPA03001546A (es) 2004-12-13
DE60137431D1 (de) 2009-03-05
ATE420626T1 (de) 2009-01-15
AU7997001A (en) 2002-03-04
EP1311241A2 (en) 2003-05-21
KR20030040418A (ko) 2003-05-22
CA2420194A1 (en) 2002-02-28
US20040265350A1 (en) 2004-12-30
RU2283140C2 (ru) 2006-09-10
EP1311241B1 (en) 2009-01-14
HUP0303111A2 (hu) 2003-12-29
WO2002015881A2 (en) 2002-02-28
AU2001279970B2 (en) 2006-08-10
CN1469736A (zh) 2004-01-21

Similar Documents

Publication Publication Date Title
DE60137431D1 (de) Verwendung eines porösen trägermaterials
BR0008322A (pt) Implante
ATE304011T1 (de) Hydantoin-enthaltende glucokinase aktivatoren
ID29642A (id) Lembaran berpori, benda penyerap yang menggunakan lembaran berpori dan metode pembuatannya
DK1169312T3 (da) Glucokinaseaktivatorer
DK1242397T3 (da) Trans-olefiniske glucokinaseaktivatorer
BR0215020A (pt) Sistema mecânico de fixação para um artigo absorvente
DE60025107D1 (de) Porenhaltige Materialien
DE60131601D1 (de) Poröses Material
UY26850A1 (es) Activadores de la benzeno acetamida glucoquinasa alfa-acil y alfa-heteroátomo sustituida.
DE69909331D1 (de) Intelligenter poröser film oder intelligentes poröses material
JP2005501039A (ja) 可変放出割合を持つ薬剤制御放出システム
DK1283830T3 (da) Para-amin-substituerede phenylamidglucokinase-aktivatorer
DE69923594D1 (de) Flammhemmende, mikroporöse materialien
BR0005401B1 (pt) artigo absorvente.
DE60126838D1 (de) Amidoacetonitrile zur Bekämpfung von Endoparasiten
SE0300694D0 (sv) Absorberande alster med förbättrat ytmaterial
DE60005031D1 (de) Partikel mit kontrollierter freisetzungsrate
BR0105704B1 (pt) meio para fixação de artigo absorvente de gotejamento corporal em peça ìntima.
DE50112406D1 (de) Wundauflage mit verminderter verwachsungstendenz
DE60115960D1 (de) Absorbierendes produkt
AU3827100A (en) Absorbent material, consisting of a porous matter with double porosity
DE60004895D1 (de) Reibwerkstoff für Nasslaufkupplungen, mit kontrollierter Porosität
DE50004429D1 (de) Keramischer wabenkörper mit einlagerung
DE60030708D1 (de) Beschichtete Hartmetallkörper

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)